They found that the higher iron supplementation (3 mg/L and 15 mg/L) added at this early timepoint resulted in a reduced frequency of anemia and low transferrin saturation compared with the infants who were given the 1.7 mg/L iron supplementation [22]. This evidence concerns the gene TF and anemia.